Kim Zoski

546 total citations
12 papers, 480 citations indexed

About

Kim Zoski is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Kim Zoski has authored 12 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 3 papers in Psychiatry and Mental health. Recurrent topics in Kim Zoski's work include Pharmacological Receptor Mechanisms and Effects (6 papers), Receptor Mechanisms and Signaling (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Kim Zoski is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (6 papers), Receptor Mechanisms and Signaling (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Kim Zoski collaborates with scholars based in United States and France. Kim Zoski's co-authors include Thomas A. Pugsley, Lawrence D. Wise, David J. Wustrow, Thomas G. Heffner, Steven Z. Whetzel, Hyacinth C. Akunne, Thomas R. Belliotti, Suzanne R. Kesten, Ann E. Corbin and John R. Rubin and has published in prestigious journals such as Journal of Medicinal Chemistry, Neuropharmacology and Progress in Neuro-Psychopharmacology and Biological Psychiatry.

In The Last Decade

Kim Zoski

12 papers receiving 462 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kim Zoski 321 179 101 55 28 12 480
George D. Maynard 237 0.7× 113 0.6× 89 0.9× 39 0.7× 39 1.4× 25 451
Thomas E. Christos 213 0.7× 155 0.9× 43 0.4× 26 0.5× 46 1.6× 16 358
Gabriella Gentile 132 0.4× 218 1.2× 166 1.6× 22 0.4× 16 0.6× 35 445
Jeffrey A. Deskus 230 0.7× 155 0.9× 44 0.4× 36 0.7× 7 0.3× 15 353
Kethireddy V.V. Ananthalakshmi 183 0.6× 147 0.8× 122 1.2× 39 0.7× 9 0.3× 21 463
Paul Krenitsky 172 0.5× 104 0.6× 28 0.3× 19 0.3× 33 1.2× 10 286
Bruce M. Bechle 142 0.4× 128 0.7× 19 0.2× 23 0.4× 15 0.5× 14 257
J. Borgulya 132 0.4× 102 0.6× 78 0.8× 13 0.2× 23 0.8× 13 413
Lakmal W. Boteju 172 0.5× 324 1.8× 176 1.7× 24 0.4× 8 0.3× 20 533
Matthias Brewer 593 1.8× 151 0.8× 61 0.6× 33 0.6× 7 0.3× 44 749

Countries citing papers authored by Kim Zoski

Since Specialization
Citations

This map shows the geographic impact of Kim Zoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Zoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Zoski more than expected).

Fields of papers citing papers by Kim Zoski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Zoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Zoski. The network helps show where Kim Zoski may publish in the future.

Co-authorship network of co-authors of Kim Zoski

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Zoski. A scholar is included among the top collaborators of Kim Zoski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Zoski. Kim Zoski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Pettersson, Martin, Brian Campbell, Amy B. Dounay, et al.. (2010). Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists. Bioorganic & Medicinal Chemistry Letters. 21(2). 865–868. 11 indexed citations
2.
Dounay, Amy B., Nancy S. Barta, Brian Campbell, et al.. (2009). Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists. Bioorganic & Medicinal Chemistry Letters. 20(3). 1114–1117. 9 indexed citations
3.
Konkel, Michael J., Bharat Lagu, Lakmal W. Boteju, et al.. (2006). 3-Arylimino-2-indolones Are Potent and Selective Galanin GAL3 Receptor Antagonists. Journal of Medicinal Chemistry. 49(13). 3757–3758. 43 indexed citations
4.
Pugsley, Thomas A., Steven Z. Whetzel, Kim Zoski, et al.. (2002). The discovery of PD 89211 and related compounds: Selective dopamine D4 receptor antagonists. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(2). 219–226. 12 indexed citations
5.
Akunne, Hyacinth C., et al.. (2001). Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant. Neuropharmacology. 41(1). 138–149. 30 indexed citations
6.
Akunne, Hyacinth C., Kim Zoski, M. Duff Davis, et al.. (2000). PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. I. Neurochemical effects. Neuropharmacology. 39(7). 1197–1210. 5 indexed citations
7.
Belliotti, Thomas R., David J. Wustrow, Kim Zoski, et al.. (1999). A Series of 6- and 7-Piperazinyl- and -Piperidinylmethylbenzoxazinones with Dopamine D4 Antagonist Activity:  Discovery of a Potential Atypical Antipsychotic Agent. Journal of Medicinal Chemistry. 42(25). 5181–5187. 19 indexed citations
8.
Wustrow, David J., Thomas Capiris, Hyacinth C. Akunne, et al.. (1998). Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(16). 2067–2070. 111 indexed citations
9.
Belliotti, Thomas R., Suzanne R. Kesten, John R. Rubin, et al.. (1998). Isoindolinone enantiomers having affinity for the dopamine D4 receptor. Bioorganic & Medicinal Chemistry Letters. 8(12). 1499–1502. 194 indexed citations
10.
Wustrow, David J., Thomas R. Belliotti, Shelly A. Glase, et al.. (1998). Aminopyrimidines with High Affinity for Both Serotonin and Dopamine Receptors. Journal of Medicinal Chemistry. 41(5). 760–771. 25 indexed citations
11.
Belliotti, Thomas R., Suzanne R. Kesten, John R. Rubin, et al.. (1997). Novel cyclohexyl amides as potent and selective D3 dopamine receptor ligands. Bioorganic & Medicinal Chemistry Letters. 7(18). 2403–2408. 15 indexed citations
12.
Akunne, Hyacinth C., Kim Zoski, Andrea M. Sefler, et al.. (1996). Functional activity of new C-terminal cyclic-neurotensin fragment analogs. Neuropeptides. 30(3). 213–218. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George D. Maynard Breakdown of academic impact, for papers by Thomas E. Christos Breakdown of academic impact, for papers by Gabriella Gentile Breakdown of academic impact, for papers by Jeffrey A. Deskus Breakdown of academic impact, for papers by Kethireddy V.V. Ananthalakshmi Breakdown of academic impact, for papers by Paul Krenitsky Breakdown of academic impact, for papers by Bruce M. Bechle Breakdown of academic impact, for papers by J. Borgulya Breakdown of academic impact, for papers by Lakmal W. Boteju Breakdown of academic impact, for papers by Matthias Brewer
Rankless by CCL
2026